2,104
Views
23
CrossRef citations to date
0
Altmetric
Review Article

Tranexamic acid for treatment of primary postpartum hemorrhage after vaginal delivery: a systematic review and meta-analysis of randomized controlled trials

, ORCID Icon, , , , , , & show all
Pages 869-874 | Received 09 Apr 2018, Accepted 10 Jul 2018, Published online: 10 Sep 2018

References

  • World Health Organization (WHO). WHO recommendations for the prevention and treatment of postpartum hemorrhage. Geneva: World Health Organization; 2012.
  • AbouZahr C. Global burden of maternal death and disability. Br Med Bull. 2003;67:1–11.
  • Bonnar J. Massive obstetric haemorrhage. Baillieres Best Pract Res Clin Obstet Gynaecol. 2000;14:1–18.
  • Westhoff G, Cotter AM, Tolosa JE. Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage. Cochrane Database Syst Rev. 2013;(10):CD001808.
  • Saccone G, Caissutti C, Ciardulli A, et al. Uterine massage as part of active management of the third stage of labour for preventing postpartum haemorrhage during vaginal delivery: a systematic review and meta-analysis of randomised trials. BJOG. 2018;125:778–781.
  • Petrov DA, Karlberg B, Singh K, et al. Perioperative internal iliac artery balloon occlusion, in the setting of placenta accreta and its variants: the role of the interventional radiologist. Curr Probl Diagn Radiol. 2017[Nov 10]. doi: 10.1067/j.cpradiol.2017.10.010
  • Simonazzi G, Bisulli M, Saccone G, et al. Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials. Acta Obstet Gynecol Scand. 2016;95:28–37.
  • Simonazzi G, Saccone G, Berghella V. Evidence on the use of tranexamic acid at cesarean delivery. Acta Obstet Gynecol Scand. 2016;95:837.
  • Li C, Gong Y, Dong L, et al. Is prophylactic tranexamic acid administration effective and safe for postpartum hemorrhage Prevention? A systematic review and meta-analysis. Medicine. 2017;96:e5653.
  • Ker K, Shakur H, Roberts I. Does tranexamic acid prevent postpartum haemorrhage? A systematic review of randomised controlled trials. BJOG. 2016;123:1745–1752.
  • Shakur H, Roberts I, Fawole B, et al. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet. 2017;389:2105–2116.
  • Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions, version 5.1.0 (update March 2011) [Internet]. The Cochrane Collaboration; 2011 [cited 2018 Feb 20]. Available from: training.cochrane.org/handbook.
  • Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62:1006–1012.
  • Ducloy-Bouthors AS, Jude B, Duhamel A, et al. High-dose tranexamic acid reduces blood loss in postpartum haemorrhage. Crit Care. 2011;15:R117.
  • Yang H, Zheng S, Shi C. Clinical study on the efficacy of tranexamic acid in reducing postpartum blood lose: a randomized, comparative, multicenter trial. Zhonghua Fu Chan Ke Zhi. 2001;36:590–592.
  • Gungorduk K, Asıcıoğlu O, Yıldırım G, et al. Can intravenous injection of tranexamic acid be used in routine practice with active management of the third stage of labor in vaginal delivery? A randomized controlled study. Amer J Perinatol. 2012;30:407–413.
  • Mirghafourvand M, Mohammad-Alizadeh S, Abbasalizadeh F, et al. The effect of prophylactic intravenous tranexamic acid on blood loss after vaginal delivery in women at low risk of postpartum haemorrhage: a double-blind randomised controlled trial. Aust N Z J Obstet Gynaecol. 2015;55:53–58.
  • Sentilhes L, Winer N, Azria E, et al. Tranexamic acid for the prevention of postpartum hemorrhage after vaginal delivery: the TRAAP trial. Am J Obstet Gynecol. 2018;218:S2–S3.
  • Shakur H, Beaumont D, Pavord S, et al. Antifibrinolytic drugs for treating primary postpartum haemorrhage. Cochrane Database Syst Rev. 2018;2:CD012964.
  • Pilbrant A, Schannong M, Vessman J. Pharmacokinetics and bioavailability of tranexamic acid. Eur J Clin Pharmacol. 1981;20:65–72.
  • Perel P, Ker K, Morales Uribe CH, et al. Tranexamic acid for reducing mortality in emergency and urgent surgery. Cochrane Database Syst Rev. 2013;(1):CD010245.
  • Yeguiayan JM, Rosencher N, Vivien B. Early administration of tranexamic acid in trauma patients. Lancet. 2011;378:27–28.
  • Poeran J, Rasul R, Suzuki S, et al. Tranexamic acid use and postoperative outcomes in patients undergoing total hip or knee arthroplasty in the United States: retrospective analysis of effectiveness and safety. BMJ. 2014;349:g4829.
  • Saccone G, Berghella V, Maruotti GM, et al. Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study. Am J Obstet Gynecol. 2017;216:525.e1–525.e12.
  • Saccone G, Berghella V, Sarno L, et al. Celiac disease and obstetric complications: a systematic review and metaanalysis. Am J Obstet Gynecol. 2016;214:225–234.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.